Lipid mediators in plasma of autism spectrum disorders

Lipids Health Dis. 2012 Nov 21:11:160. doi: 10.1186/1476-511X-11-160.


Background: Inflammation is increasingly recognized as being of both physiological and pathological importance in the immature brain. Cerebellar pathology occurs in autism, as a neurodevelopmental disorder with genetic and environmental origins. The genesis of this disorder is still not understood but inflammation in utero or early in childhood is an environmental risk factor.

Methods: Prostaglandin E2 (PGE2), cysteinyl leukotriene as two important lipid mediators together with 8 isoprostane as marker of oxidative stress were measured using ELISA in plasma of 20 male autistic patients compared to 19 age and gender matching control participants.

Results: PGE2, leukotrienes and isoprostanes recorded significantly elevated levels in autistics compared to controls. Role of these measured parameters in inflammation and autoimmunity as two etiological factors in autism were discussed in details.

Conclusion: Receiver Operating Characteristic (ROC) curve analysis shows satisfactory values of area under the curve (AUC) which could reflect the high degree of specificity and sensitivity of the altered PGE2, leukotrienes and isoprostanes as predictive biomarkers in autistic patients from Saudi Arabia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Brain / metabolism
  • Brain / physiopathology
  • Child
  • Child Development Disorders, Pervasive* / blood
  • Child Development Disorders, Pervasive* / physiopathology
  • Child, Preschool
  • Dinoprostone / blood*
  • Humans
  • Inflammation / blood
  • Inflammation / physiopathology
  • Isoprostanes / blood*
  • Leukotrienes / blood*
  • Lipid Metabolism* / genetics
  • Lipid Metabolism* / physiology
  • Male
  • ROC Curve
  • Saudi Arabia


  • Biomarkers
  • Isoprostanes
  • Leukotrienes
  • Dinoprostone